Fabrinet Q3 FY23 revenue $665.3M beats guidance; GAAP EPS $1.60, non-GAAP $1.94; COO Gill transition

Fabrinet

2023-Q3 EPS reported $5.07 revenue$1,989,366,000

Q3 revenue $665.3M (record), above guidance; GAAP EPS $1.60, Non-GAAP EPS $1.94.
Non-GAAP net income $71.8M, up from $56.2M YoY; net income per diluted share $1.94 vs $1.50.
Q4 FY23 guidance: revenue $630–650M, GAAP EPS $1.57–1.64, Non-GAAP EPS $1.76–1.83.
COO Dr. Harpal Gill to transition to EVP role effective Jan 1, 2025; base salary $1,040,300, bonus ≥95%.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Dr. Harpal Gill

Executive Vice President

FN · Fabrinet

Effective: 2025-01-01
Filed: May 8, 2023, 7:59 PM ET

Effective January 1, 2025, through December 31, 2025 (the “ retirement date ,” and such period, the “ transition period ”), and unless his employment terminates earlier pursuant to the terms of the Amended Gill Offer Letter, Dr. Gill will transition from COO to a revised role with an Executive Vice President title (“ EVP ”).

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Fabrinet reported third fiscal quarter ended March 31, 2023 results: revenue $665.3 million, net income $59.4 million, EPS $1.60. Guidance initiated.

Period: third fiscal quarter ended March 31, 2023
Revenue: $665.3 million
Net income: $59.4 million
EPS: $1.60
Guidance: initiated
Result: reported results

Exact text from the filing

Fabrinet Announces Third Quarter Fiscal Year 2023 Financial Results • Record Third Quarter Revenue of $665.3 Million Exceeds Guidance

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Harpal Gill changed role as Executive Vice President at Fabrinet.

Action: transition
Role: Executive Vice President

Exact text from the filing

Effective January 1, 2025, through December 31, 2025 (the “ retirement date ,” and such period, the “ transition period ”), and unless his employment terminates earlier pursuant to the terms of the Amended Gill Offer Letter, Dr. Gill will transition from COO to a revised role with an Executive Vice President title (“ EVP ”).

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Fabrinet filing history →

Source: SEC EDGAR

accession 0001408710-23-000016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.